+91-9660032889
support@mysiponline.com
TATA India Pharma & Health Care Fund Regular Plan - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Very High
-
₹30.94
(0.21%)
Current NAV 26-12-2024
-
40%
Returns
-
Min. SIP ₹100
Min. Investment ₹5000
Fund Suitability Test
Asset Allocation (As on 31-Oct-2024)
Allocation of Equity and Debt Asset Classes.
- Equity 94.61%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Large Cap | 40.33 |
| Mid Cap | 30.82 |
| Small Cap | 23.46 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Pharmaceuticals & Biotechnology
Healthcare Services
Insurance
Fertilizers & Agrochemicals
Retailing
Chemicals & Petrochemicals
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 13-Mar-2024 |
Holdings | PE Ratio 13-Mar-2024 |
1Y Return |
|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 12.31% | 39.97 | 47.75% |
| AUROBINDO PHARMA LTD | Mid Cap | Pharmaceuticals & Biotechnology (48.89) | 8.57% | 20.38 | 18.18% |
| LUPIN LTD | Mid Cap | Pharmaceuticals & Biotechnology (132.95) | 7.43% | 167.31 | 197.56% |
| DR REDDYS LABORATORIES LTD | Large Cap | Pharmaceuticals & Biotechnology | 6.48% | - | 0% |
| CIPLA LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 6.29% | 26.89 | 19.64% |
| DIVI LABORATORIES LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 5.12% | 85.57 | 53.25% |
| FORTIS HEALTHCARE LTD | Mid Cap | Healthcare Services (97.63) | 4.42% | 77.91 | 70.89% |
| ZYDUS LIFESCIENCES LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 3.91% | 21.72 | 41.66% |
| ALKEM LABORATORIES LTD | Mid Cap | Pharmaceuticals & Biotechnology (38.82) | 3.6% | 57.92 | -8.63% |
| APOLLO HOSPITALS ENTERPRISE LTD | Large Cap | Healthcare Services (97.63) | 3.42% | 87.81 | 28.28% |
| ASTER DM HEALTHCARE LTD | Small Cap | Healthcare Services (97.63) | 2.42% | 4.66 | 26.02% |
| AJANTA PHARMA LTD | Mid Cap | Pharmaceuticals & Biotechnology (48.89) | 2.4% | 39.97 | 41% |
| MEDI ASSIST HEALTHCARE SERVICES LTD | Small Cap | Insurance (206.54) | 2.14% | 47.55 | 0% |
| FDC LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 2.13% | 25.85 | 26.22% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | Small Cap | Healthcare Services (97.63) | 2.11% | 115.4 | 27.29% |
| ORCHID PHARMA LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 2.11% | 75.59 | 147.55% |
| WOCKHARDT LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 1.93% | -82.49 | 248.3% |
| TORRENT PHARMACEUTICALS LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 1.88% | 64.04 | 49.47% |
| IPCA LABORATORIES LTD | Mid Cap | Pharmaceuticals & Biotechnology (48.89) | 1.87% | 61.12 | 50.43% |
| INDOCO REMEDIES LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 1.71% | 95.17 | -16.71% |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | Small Cap | Pharmaceuticals & Biotechnology | 1.33% | - | 0% |
| PIRAMAL PHARMA LTD | Small Cap | Pharmaceuticals & Biotechnology (22.59) | 1.33% | 0 | -26.02% |
| JUPITER LIFE LINE HOSPITALS LTD | Small Cap | Healthcare Services | 1.18% | - | 0% |
| SANOFI INDIA LTD | Small Cap | Pharmaceuticals & Biotechnology (24.65) | 1.08% | 8.73 | 145.06% |
| LAURUS LABS LTD | Small Cap | Pharmaceuticals & Biotechnology (46.65) | 1.04% | 0 | 9.05% |
| MANKIND PHARMA LTD | Large Cap | Pharmaceuticals & Biotechnology (48.89) | 0.92% | 56.67 | 50.86% |
| COROMANDEL INTERNATIONAL LTD | Mid Cap | Fertilizers & Agrochemicals (15.82) | 0.83% | 18.4 | 18.6% |
| AMI ORGANICS LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 0.82% | 99.68 | 93.35% |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | Small Cap | Pharmaceuticals & Biotechnology | 0.78% | - | 0% |
| SYNGENE INTERNATIONAL LTD | Mid Cap | Healthcare Services (71.84) | 0.76% | 70.18 | 20.01% |
| PROCTER & GAMBLE HEALTH LTD | Small Cap | Pharmaceuticals & Biotechnology (48.89) | 0.69% | 0 | 9.99% |
| MEDPLUS HEALTH SERVICES LTD | Small Cap | Retailing (48.89) | 0.66% | 99.47 | 14.26% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | Mid Cap | Pharmaceuticals & Biotechnology (48.89) | 0.55% | 55.96 | 26.24% |
| DEEPAK NITRITE LTD | Mid Cap | Chemicals & Petrochemicals (50.61) | 0.39% | 41.05 | 3.7% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for TATA India Pharma & Health Care Fund Regular Plan ?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for TATA India Pharma & Health Care Fund Regular Plan ?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.